TheKicksShrink
TheKicksShrink
Harm Reduction & Buprenorphine /// Psychiatrist Explains Suboxone & Medication Assisted Treatment
Harm Reduction & Buprenorphine /// Psychiatrist Explains Suboxone & Medication Assisted Treatment
Harm Reduction & Buprenorphine /// Psychiatrist Explains Suboxone & Medication Assisted Treatment
Thursday 1st September 2022
Join Dr. Sulman Aziz Mirza on TheKicksShrink Podcast as he discusses harm reduction and medication-assisted treatment for opioid use disorder.
Explicit
7 minutes
Informative
Compassionate
Engaging
Thought-provoking
Supportive
About this podcast
Author:
TheKicksShrink
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Recovery from Trauma
Mindfulness & Technology in Health
Sexual Stigmas & Myths
Links:
Visit site
Episodes:
132 (View all)
Do you want to link to this podcast?
Get the buttons here!Harm Reduction & Buprenorphine: A Compassionate Approach to Opioid Use Disorder
When we talk about public policy towards substance use, one of the biggest missteps in the history of the world has been the war on drugs. That's never going to win. So there has to be a fundamental shift in how we're thinking about how do we help people out.
Imagine grappling with the opioid epidemic on a personal level. It's a struggle that millions face daily, and one that demands empathy and effective solutions. In this thought-provoking episode of TheKicksShrink Podcast, Dr. Sulman Aziz Mirza, MD, dives into the realm of harm reduction and medication-assisted treatment (MAT) for opioid use disorder. Dr. Mirza, a staunch advocate for harm reduction, breaks down what this approach truly means and why it's crucial in today's fight against opioid misuse.
Harm reduction isn't about endorsing drug use; it's about minimizing the negative consequences associated with it. Dr. Mirza sheds light on how inconsistent drug supplies contribute to overdose deaths and other harmful behaviors. He discusses practical harm reduction strategies like supervised injection sites and heroin maintenance programs that have shown promise in reducing these adverse effects. Central to the episode is the role of medication-assisted treatment in managing opioid addiction. Dr.
Mirza highlights buprenorphine, a partial agonist that helps reduce withdrawal symptoms and cravings while blocking the effects of other opioids. He emphasizes the importance of patient choice and having a robust support system when considering MAT options. But it doesn't stop at medication. Dr. Mirza also delves into the psychological and social dimensions of substance use disorder. He underscores the necessity of developing coping skills and building a strong support network for long-term recovery.
This episode offers a compassionate, evidence-based perspective on managing opioid use disorder, making it a must-listen for anyone affected by or interested in this pressing issue.